You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 4, 2025

Drug Price Trends for NDC 82009-0029


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 82009-0029

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

82009-0029 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 82009-0029

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number assigned by the FDA to identify drug products. It includes the labeler code, product code, and package code, providing a comprehensive identifier for each drug product[1][4].

Identifying the Drug

The NDC 82009-0029 corresponds to a specific drug product. Here, the labeler code, product code, and package code need to be deciphered to identify the drug. For instance, the labeler code '82009' identifies the manufacturer or distributor, while the product code and package code specify the exact formulation and packaging of the drug[4].

Market Dynamics

Pricing Trends

When analyzing the market dynamics for a specific drug, pricing trends are a critical factor. Historical data shows that drug prices can fluctuate, but these changes are often minimal and infrequent. For example, a study on drug prices found that only about 1% of prices changed in most weeks, and the median price increase was approximately 7% in any given week[3].

Competition and Patent Expiration

The life sciences industry is facing significant challenges, including competition from generic drugs and biosimilars, as well as the patent cliff. With over $300 billion in sales at risk through 2030 due to expiring patents, companies are likely to focus on new product development and strategic acquisitions to maintain market share[5].

Regulatory Environment

The regulatory environment plays a vital role in drug pricing and market dynamics. Drugs listed in the NDC Directory must comply with FDA regulations, including submission of product listing data and adherence to the Drug Listing Act. Non-compliance can result in the exclusion of the drug from the NDC Directory[1][4].

Price Projections

Historical Price Analysis

To project future prices for the drug NDC 82009-0029, historical price data is essential. Analyzing past price changes can help predict future trends. For instance, if the drug has historically seen minimal price fluctuations, it is likely to continue this pattern unless significant market or regulatory changes occur[3].

Market Forces

Market forces such as competition, regulatory changes, and economic conditions can impact price projections. For example, if a generic version of the drug is introduced, it could lead to a decrease in the price of the branded version. Similarly, changes in reimbursement policies or healthcare regulations can influence pricing strategies[5].

Technological and Innovative Trends

The integration of technologies like artificial intelligence (AI) and the use of large language models (LLMs) in the pharmaceutical industry can also impact pricing. AI-driven drug discovery and personalized medicine may lead to more efficient and cost-effective treatments, potentially altering market dynamics and pricing strategies[2].

Case Study: Impact of AI and Digital Transformation

The increasing adoption of AI in the pharmaceutical industry is expected to double in 2025, with more companies using external data to train internal models. This trend could lead to more efficient drug development and reduced costs, which might reflect in pricing. For instance, AI-powered clinical trial design and real-time patient monitoring could streamline the development process, reducing the overall cost of bringing a drug to market[2].

Key Takeaways

  • Unique Identification: The NDC 82009-0029 uniquely identifies a drug product, including its manufacturer, formulation, and packaging.
  • Pricing Trends: Historical data indicates that drug prices tend to have minimal and infrequent changes.
  • Market Dynamics: Competition from generics, patent expirations, and regulatory compliance are key factors influencing market dynamics.
  • Technological Impact: AI and digital transformation are expected to enhance efficiency and potentially reduce costs in drug development.
  • Regulatory Compliance: Adherence to FDA regulations is crucial for maintaining the drug's presence in the market.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package code.

Q: How often do drug prices change? A: Drug prices tend to change infrequently, with only about 1% of prices changing in most weeks.

Q: What are the major challenges facing the life sciences industry in 2025? A: The industry faces challenges such as competition from generic drugs and biosimilars, patent expirations, and pricing and access issues.

Q: How is AI impacting the pharmaceutical industry? A: AI is expected to enhance efficiency in drug development, clinical trials, and patient monitoring, potentially reducing costs and improving outcomes.

Q: What role does regulatory compliance play in drug pricing? A: Regulatory compliance is crucial as non-compliance can result in the exclusion of the drug from the NDC Directory and affect its market presence.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch - Intelligencia.ai
  3. Temporary Medicare-Approved Drug Discount Card: Analysis of Drug Prices - OIG.HHS.gov
  4. National Drug Code Database Background Information - FDA
  5. 2025 Life Sciences Executive Outlook - Deloitte Insights

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.